EcoR1 Capital, LLC is a biotech focused investment advisory firm. 

Intellia Therapeutics

Centessa Pharmaceuticals

2seventy bio

Arcus Biosciences

Solid Biosciences

Tango Therapeutics

Cerevel Therapeutics

Nurix Therapeutics

Pardes Biosciences

Ardelyx

Avidity Biosciences

UNITY Biotechnology

Relay Therapeutics

Janux Therapeutics

Kronos Bio

Kymera Therapeutics

Magenta Therapeutics

Neogene Therapeutics

SAGE Therapeutics

Cyclerion Therapeutics

Editas Medicine

Shattuck Labs

Fulcrum Therapeutics

EcoR1 Capital, LLC

Google Tag Manager

Amazon

Global Site Tag

US Privacy User Signal Mechanism

Cloudflare CDN

Cloudflare Hosting

Cloudflare

Amazon Route 53

Cloudflare Insights

Cloudflare Web Analytics

Founder and Managing Director

Oleg Nodelman

Scott Perlen

Director of Partner Relations

Catherine McWilliams

Controller

Oleg Khusainov

Analyst

Basheer Zada

Partner

Caroline Stout

Administrative Assistant

Cheryl Wessels

Chief of Staff

Kristin Fabianski

Finance and Administration

Madelyn Gehrich

Operations Associate

Miranda Fornaro

Scott Platshon

Investor

Founder & Managing Director

Alex Tkachenko

Entrepreneur In Residence

Principal

Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies for its patients.

Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer.

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

Western US Investors with Funds Raised in 2017

Post IPO Investors with Investments in Greater Boston Area

Private Equity Firms with Investments in California

Venture Stage Investors with Investments in West Coast

EcoR1 Capital is an investment advisory firm focused on the biotech industry. They aim to identify and evaluate innovative therapeutic solutions that can bring significant improvements to patients' lives. Drawing inspiration from the transformative power of the EcoR1 restriction enzyme in the biomedical field, they invest in biotech companies that offer promising new treatments for untreated diseases. EcoR1 Capital recognizes the importance of building upon the innovative contributions of its predecessors in order to continue advancing medical research.

EcoR1 Venture Opportunity Fund, LP

EcoR1 Venture Opportunity Fund

EcoR1 Capital Fund Qualified, L.P.

EcoR1 Capital Fund, L.P.

San Francisco

California

United States

North America

EcoR1 Capital

Casdin Capital Leads a Strong Month for Biopharma Funds

The Netherlands

Europe

United Kingdom

Bangladesh

Asia

RA Capital Management is a private investment firm that focuses on investments in healthcare and life sciences companies.

RA Capital Management

Chrys Capital is a private equity firm that primarily invests in companies in India and Asia.

Chrys Capital

gumi Cryptos Capital (gCC) is a private investment firm that focuses on blockchain and cryptocurrency-related investments.

gumi Cryptos Capital (gCC)

Ecor1 Capital is a private equity firm that specializes in growth equity investments in the technology sector. The firm focuses on partnering with innovative companies that have a positive impact on the environment and society, particularly in the fields of energy, mobility, and sustainability.

Ecor1 Capital

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 11, 2024 5:30 PM	bda69818
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 11, 2024 7:32 PM	c3b580e8
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	32a9141c
crunchbase profile	general	Nov 25, 2024 11:38 AM	3687259d
li profile	general	May 11, 2024 5:30 PM	4e8c2196
translate crunchbase fundingrounds	general	Nov 25, 2024 2:08 PM	baf79bb0
peers	general
news basic	general	May 11, 2024 5:30 PM	7479d1e4
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:ECOR1CAP

Ecor1 Capital